{"url_path":"/sec/neo/8-k/2026-06-17/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-17","source_url":"https://www.sec.gov/Archives/edgar/data/1077183/0001077183-26-000031-index.html","accession_number":"0001077183-26-000031","cik":"0001077183","ticker":"NEO","issuer_name":"NEOGENOMICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1077183/0001077183-26-000031-index.html","primary_entity_key":"0001077183","primary_entity_name":"NEOGENOMICS INC"},"word_count":133,"has_tables":true,"body_markdown":"Item 8.01Other Events.\n\nOn June 17, 2026, NeoGenomics, Inc. (the “Company”) issued a press release relating to the pricing of its offering of convertible senior notes due 2032 to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Convertible Notes Offering”). A copy of the press release relating to the Convertible Notes Offering is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.\n\nThis Current Report on Form 8-K, including the exhibit attached hereto, does not constitute an offer to sell or the solicitation of an offer to buy any securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offering, solicitation or sale would be unlawful."}